Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $70.11 million. The enterprise value is $63.47 million.
| Market Cap | 70.11M |
| Enterprise Value | 63.47M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 25.93 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Shares Outstanding | 25.93M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 65.38% |
| Owned by Institutions (%) | 28.09% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 10.81 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.73, with zero debt.
| Current Ratio | 6.73 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -328.54 |
Financial Efficiency
Return on equity (ROE) is -109.40% and return on invested capital (ROIC) is -164.36%.
| Return on Equity (ROE) | -109.40% |
| Return on Assets (ROA) | -98.40% |
| Return on Capital (ROIC) | -164.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.25M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.21% in the last 52 weeks. The beta is -1.01, so ANEB's price volatility has been lower than the market average.
| Beta (1Y) | -1.01 |
| 52-Week Price Change | -0.21% |
| 50-Day Moving Average | 2.74 |
| 200-Day Moving Average | 2.60 |
| Relative Strength Index (RSI) | 51.18 |
| Average Volume (30 Days) | 5,901 |
Short Selling Information
The latest short interest is 20,117, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 20,117 |
| Short Previous Month | 18,841 |
| Short % of Shares Out | 0.08% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.66M |
| Pretax Income | -10.49M |
| Net Income | -10.49M |
| EBITDA | -10.46M |
| EBIT | -10.46M |
| Earnings Per Share (EPS) | -$0.42 |
Balance Sheet
The company has $6.64 million in cash and no debt, giving a net cash position of $6.64 million or $0.26 per share.
| Cash & Cash Equivalents | 6.64M |
| Total Debt | n/a |
| Net Cash | 6.64M |
| Net Cash Per Share | $0.26 |
| Equity / Book Value | 6.49M |
| Book Value Per Share | 0.25 |
| Working Capital | 5.80M |
Cash Flow
| Operating Cash Flow | -9.58M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.58M |
| FCF Per Share | -$0.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | -14.96% |
| FCF Yield | -13.66% |
Analyst Forecast
The average price target for ANEB is $6.67, which is 146.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.67 |
| Price Target Difference | 146.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |